Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Neuropathy Centers is a specialized healthcare provider network focused on the diagnosis and treatment of peripheral neuropathy and related chronic nerve conditions. The company utilizes a multidisciplinary approach, combining advanced diagnostic testing such as epidermal nerve fiber density (ENFD) biopsies with both surgical and non-surgical interventions. Their primary clinical offerings include nerve decompression surgery, electrical signal therapy, and regenerative medicine techniques aimed at restoring nerve function and reducing pain. US Neuropathy Centers operates multiple clinics across the United States, providing specialized care for patients suffering from diabetic, idiopathic, and chemotherapy-induced neuropathy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Neuropathy Centers.